Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status

Published Date: 22 Sep 2026

Ivonescimab topped pembrolizumab alone or paired with chemotherapy in separate trials

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

MRI can save rectal cancer patients from surgery, study suggests

2.

When Healthcare Chatbots Fall Short of Human Connection

3.

Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL

4.

Antibiotic Use in Hospice Linked to Higher Mortality Risk

5.

Two Survival Wins in NSCLC With Bispecific Seeking Worldwide Status


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot